U.S. Clinical Labs Develop New Technology to Detect Breast Cancer in Early Stages
Ja ja ja, ¡fuiste engañado!
¡ERA UNA BROMA!
Hace 5 meses - Leído 49 veces
A team of scientists from various U.S clinical labs has developed a new technology that can detect breast cancer in an early stage with a 99% accuracy rate. The technology, called "Bio-Scan", uses a molecular sensor to detect the presence of cancer cells in a blood sample. The researchers developed Bio-Scan in response to the need to improve early detection methods for breast cancer. Current tests, such as mammograms and cytology, have limited sensitivity and may not detect cancer until it is in an advanced stage. Bio-Scan works by identifying specific molecules that are found in breast cancer cells. These molecules detach from cancer cells and spread into the blood. Bio-Scan's molecular sensor is capable of detecting these molecules in blood, even in very small quantities. The researchers tested Bio-Scan on a group of 1,000 women at risk for breast cancer. The technology detected cancer in all women who had the disease, including some who had not been detected by current tests. The researchers believe that Bio-Scan could represent a significant breakthrough in early detection of breast cancer. The technology is still in development, but the researchers hope that it may be available to the public in the coming years.
